AB0568 CLINICAL USE OF ACTIVATED LEUKOCYTE CELL ADHESION MOLECULE, HEMOPEXIN, AND PEROXIREDOXIN 6: A...
AB0568 CLINICAL USE OF ACTIVATED LEUKOCYTE CELL ADHESION MOLECULE, HEMOPEXIN, AND PEROXIREDOXIN 6: A POTENTIAL URINE BIOMARKER FOR KOREAN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
About this item
Full title
Author / Creator
Kim, J. W. , Jung, J. Y. , Kim, H. A. and Suh, C. H.
Publisher
Kidlington: BMJ Publishing Group Ltd and European League Against Rheumatism
Journal title
Language
English
Formats
Publication information
Publisher
Kidlington: BMJ Publishing Group Ltd and European League Against Rheumatism
Subjects
More information
Scope and Contents
Contents
BackgroundSystemic lupus erythematosus (SLE) is sometimes difficult to make a prompt and accurate diagnosis due to the heterogeneity of various clinical manifestations and autoantibody expression. Therefore, the development of surrogate markers specific to the diagnosis of SLE is necessary. Among biological samples, urine is non-invasive means with...
Alternative Titles
Full title
AB0568 CLINICAL USE OF ACTIVATED LEUKOCYTE CELL ADHESION MOLECULE, HEMOPEXIN, AND PEROXIREDOXIN 6: A POTENTIAL URINE BIOMARKER FOR KOREAN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_2825315965
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2825315965
Other Identifiers
ISSN
0003-4967
E-ISSN
1468-2060
DOI
10.1136/annrheumdis-2023-eular.933
